Parian Global Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Parian Global Management’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$237K	Sell	184,799 -211,083	-53%	-$460K	0.77%	24
2022 Q2	$970K	Sell	395,882 -63,579	-14%	-$302K	4.44%	10
2022 Q1	$3.18M	Sell	459,461 -115,245	-20%	-$1.22M	6.55%	5
2021 Q4	$9.14M	Buy	574,706 +48,390	+9%	+$969K	7.34%	2
2021 Q3	$10.6M	Buy	526,316 +12,500	+2%	+$323K	7.36%	3
2021 Q2	$15.9M	Sell	513,816 -319,673	-38%	-$9.57M	6.81%	2
2021 Q1	$21.4M	Sell	833,489 -242,195	-23%	-$6.07M	9.78%	2
2020 Q4	$17.2M	Buy	1,075,684 +220,503	+26%	+$2.72M	4.3%	3
2020 Q3	$10.4M	Buy	+855,181	New	+$12.3M	3.31%	10

Other funds holding RNLX

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parian Global Management's RNLX Position: Q3 2022 in Review

Parian Global Management reduced its Renalytix plc American Depositary Shares (RNLX) stake by 53% in Q3 2022, selling an estimated $460K and leaving 184,799 shares worth $237K. The position accounts for 0.77% of the portfolio, ranked #24.

Parian Global Management first reported a position in RNLX in Q3 2020 and has held it in 9 quarters since. The position peaked at $21.4M in Q1 2021. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

Parian Global Management held 184,799 shares of Renalytix plc American Depositary Shares worth $237K as of Q3 2022.
Parian Global Management sold 211,083 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $460K.
Renalytix plc American Depositary Shares made up 0.77% of Parian Global Management's portfolio in Q3 2022, its #24 holding.
Parian Global Management first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and has held it in 9 quarters since.
Parian Global Management's Renalytix plc American Depositary Shares position peaked at $21.4M in Q1 2021.
27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.